Abstract
Time is running out to secure a post-Brexit trade deal or a “bare minimum” agreement on drugs so as to avoid significant delays to supplies to the UK, MPs have been warned. Experts from the drug, chemical, and aerospace industries have underlined the potential problems ahead after the end of the Brexit transition period in December if no trade deals are secured between the UK and the EU before then. Representatives of these industries appeared before the House of Commons Committee on the Future Relationship with the European Union during an evidence session for its inquiry held on 30 September . Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry (ABPI), told the committee’s MPs: “We need the bare minimum in order …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
